NDRI is partnering with the Lyme Disease Biobank (LDB) to collect surgical and post-mortem tissues and associated clinical information from eligible individuals with Lyme disease or other tick-borne infections. These tissues will be made available to approved investigators, providing the research community with a much-needed resource to better understand these complex infections.
Donors can also elect to enroll in the MyLymeData Patient Registry and connect their data with their tissue sample.
Providers can get involved by telling their patients about this program and giving them the resources to register.
Founded in 1980, the National Disease Research Interchange (NDRI), is a non-profit 501(c)(3) that ships thousands of biospecimens annually from our nationwide procurement network to researchers worldwide. NDRI is the nation’s leading source of human tissues, cells, and organs for scientific research. The National Institutes of Health (NIH) has provided funding to NDRI since 1987.
NDRI is accredited by the College of American Pathologists (CAP) as a biorepository and a sponsor facility. This biorepository accreditation meets the standards for human biospecimen collection, storage, informatics, and distribution defined by the CAP Biorepository Accreditation Program.